Search results
Biden's Inflation Reduction Act Unravels Medicare Part D
Forbes· 5 days agoIn May, Medicare bureaucrats released new guidance that details how they'll conduct the drug pricing...
Older Americans hit hard by Biden’s Medicare funny business
The Washington Times· 1 day agoThe federal legislation, signed into law in 2022, flips Medicare Part D upside down by empowering...
CMS Redesigns the Medicare Part D Prescription Drug Program Beginning in 2025 | JD Supra
JD Supra· 2 days agoThe Final Program Instructions reflect a newly defined standard Part D benefit design through several changes or enhancements to the Part D program beginning in 2025. Of those changes or enhancements ...
Insurers bridle over Medicare transparency push
Politico· 16 hours agoThe head of the National Institute on Drug Abuse, Nora Volkow, last month compared the hype for psychedelics as a cure for mental illness to belief in “ ...
Does Medicare Part D cover prescriptions for clinical trials?
Las Vegas Review-Journal· 6 days agoYou should always enroll in the Medicare Part D plan that covers all of your prescriptions, even...
Cost and Tafinlar: Financial assistance options, savings, more
Medical News Today· 2 days agoFind information on cost and Tafinlar, how generic and brand-name prices compare, what financial...
Potential Medicare Part D Savings on Ophthalmic Generic Drugs
Journal of the American Medical Association· 6 days agoThis economic evaluation assesses potential Medicare Part D savings on ophthalmic generic drugs if discount coupon prices are used.
Millions of Americans need drugs like Ozempic. Will it bankrupt the healthcare system?
LA Times via Yahoo News· 7 days agoIf manufacturers don't agree to reduce prices voluntarily, the federal government could take more...
Fox’s John Roberts Pushes Back in Spat With Biden Campaign After He Was Accused of a ‘Blatant Lie’
Mediaite· 12 hours agoFox News anchor John Roberts responded with receipts to President Joe Biden’s campaign accusing him...
Anti-Obesity Medications: Noteworthy Developments as Policymakers Weigh Coverage Considerations | JD...
JD Supra· 7 days agoGLP-1 agonists have ushered in a new era in anti-obesity medication policy considerations against the backdrop of a continued focus by policymakers on both drug access and ...